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Background: Carvedilol belongs to a group of medicines termed non-selective beta-adrenergic blocking agents. In
the presented approach, a practical and environmentally friendly microextraction method based on the application of
ionic liquids (ILs) was followed by fluorescence spectrometry for trace determination of carvedilol in pharmaceutical
and biological media.
Methods: A rapid and simple ionic liquid phase microextraction was utilized for preconcentration and extraction
of carvedilol. A hydrophobic ionic liquid (IL) was applied as a microextraction solvent. In order to disperse the IL
through the aqueous media and extract the analyte of interest, IL was injected into the sample solution and a proper
temperature was applied and then for aggregating the IL-phase, the sample was cooled in an ice water-bath. The
aqueous media was centrifuged and IL-phase collected at the bottom of the test tube was introduced to the
micro-cell of spectrofluorimeter, in order to determine the concentration of the enriched analyte.
Results: Main parameters affecting the accuracy and precision of the proposed approach were investigated and
optimized values were obtained. A linear response range of 10–250 μg l−1 and a limit of detection (LOD) of 1.7 μg l−1
were obtained.
Conclusion: Finally, the presented method was utilized for trace determination of carvedilol in commercial
pharmaceutical preparations and biological media.
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Carvedilol belongs to a group of medicines termed non-
selective beta-adrenergic blocking agents (Figure 1). This
drug is useful in treatment of congestive heart failure. In
addition, carvedilol is applied to treat high blood pressure
(hypertension) and for prevention of heart attacks [1,2].
In order to assay the presence of carvedilol in pharma-
ceutical and biological samples, some analytical approaches
including chromatography [3-6], spectrophotometery [7],
electrochemistry [8,9] and fluorimetry [10] have been
developed. These methods suffer form some limitations in-
cluding poor sensitivity, high cost of analysis, unsuitable* Correspondence: Zeeb.mohsen@gmail.com
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unless otherwise stated.selectivity and high time of analysis. One of the best
choices for overcoming the mentioned problems is the
combination of a practical sample enrichment method with
analytical instruments.
In recent years, analytical chemists have developed
some practical liquid phase microextraction methods
and among these sample pretreatment methods, disper-
sive liquid-liquid microextraction (DLLME) has received
much attention [11,12]. Unfortunately, one of the most
important disadvantages of these microextraction me-
thods is the usage of toxic solvents as the extraction
solvent such as CHCl3, CCl4 and etc. In order to remove
these toxic materials from microextraction procedures,
ionic liquids (ILs) are the best choice. ILs offer manytral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Structure of carvedilol.
Zeeb and Mirza DARU Journal of Pharmaceutical Sciences  (2015) 23:30 Page 2 of 7advantages such as low vapor pressure, tunable solu-
bility, desire thermal stability and etc. [13].
In recent years, some microextraction methods based
on the application of ILs such as ionic liquid-based disper-
sive liquid-liquid microextraction (IL-DLLME) [14-16],
ionic liquid cold-induced aggregation dispersive liquid-
liquid microextraction (IL-CIA-DLLME) [17-19], ionic
Liquid-based ultrasound-assisted in situ solvent formation
microextraction [20], temperature-controlled ionic liquid
dispersive liquid phase microextraction (TCIL-DLPME)
[21], etc. have been introduced.
Solubility of ILs depends on the aqueous media tem-
perature; hence it is possible to control the solubility of
ILs by changing the temperature. In the presented ionic
liquid phase microextraction, in order to disperse the
IL-phase into the sample solution and increase the ex-
traction recovery, a high temperature was applied. For
collecting the IL-phase, sample solution was cooled and
centrifuged.
Our previous studies revealed that the solubility of ILs
depends on ionic strength of aqueous media, which
has a negative influence on reproducibility and accuracy
[18,19]. For solving this problem, a common ion of IL
was introduced to the aqueous media. As a result, the
solubility of IL phase was not affected by variations of
ionic strength, and reproducible volume of enriched
phase was obtained.
Some analytical instrument such as spectrofluorimetry
offer many advantages such as proper sensitivity, selec-
tivity, cost of analysis, speed of quantitative measurements
and etc. In addition, by coupling a microextraction me-
thod with fluorescence spectrometry and due to the
proper selectivity of this analytical technique, it is avoided
the need of employing a high performance separation in-
strumental for pretreatment of biological samples prior to
measurement.
As a part of our continuing efforts for quantitation of
drugs using combination of new and benign sample en-
richment methods with inexpensive, selective and sensi-
tive analytical instrument [18,21], herein, for the first
time a practical and environmentally friendly micro-
extraction method based on the application of ILs was
followed with spectrofluorimetry for trace determination
of carvedilol in real samples. All variable were evaluated
in details and optimized values were obtained.Material and methods
Instrumentation
Detection of fluorescence signals were performed using
a Perkin-Elmer LS 50 spectrofluorimeter. This instru-
ment was equipped with xenon discharge lamp, and
quartz micro-cell with a volume of 100 μl. Excitation
and emission slits were fixed at 15 nm. In order to per-
form microextraction and optimization steps, a centri-
fuge from Hettich (Tuttlingen, Germany), a pH-meter,
an adjustable sampler (10–100 μL) and a 1 ml syringe
was prepared.
Reagents and materials
Analytical-reagent grade of 1-Hexyl-3-methylimidazolium
hexafluorophosphate [Hmim][PF6], acetone, acetonitrile,
methanol, ethanol, HCl, NaOH and sodium hexafluoro-
phosphate (NaPF6) were obtained from Merck (Darmstadt,
Germany). A working solution of NaPF6 (250 mg ml
-1)
was prepared. For preparing stock solution of carvedilol
(1000 mg l−1) (Fluka, Switzerland), proper amount of this
drug was dissolved in methanol and diluted with ultra pure
water. Standard solutions were prepared by dilution of the
stock solution with ultra pure water. Tablets containing
12.5 mg and 25 mg carvedilol were purchased from a local
pharmacy.
Sample pretreatment procedure
In this sample pretreatment method, ten milliliters of sam-
ple solution (10–250 μg l−1 of carvedilol) was transferred
to a centrifuge tube. The pH of the solution was adjusted
at 9. Afterwards, 60 mg of 1-Hexyl-3-methylimidazolium
hexafluorophosphate [Hmim][PF6] ionic liquid and 0.7 ml
of hexafluorophosphate (NaPF6) (250 mg ml
−1) was
injected into the aqueous sample solution. After mixing
the extractor with sample solution, the resultant solution
was transferred into a hot water batch equipped with a
thermostat. The temperature of the water batch was fixed
at 50°C for 4 min. Under driving the temperature, IL-
phase was dissolved and dispersed through the aqueous
media. In order to aggregate the IL-phase, the sample was
cooled at 0°C for 7 min. In order to collect the enriched
phase, sample solution was centrifuged (6 min, 4000
r.p.m). After removing the aqueous media, the enriched
phase was diluted with ethanol to 200 μl and transferred
into the micro-cell of the spectrofluorimeter. Finally,
quantitation of carvedilol was performed. Schematic dia-
gram of the designed method is shown in Figure 2.
Preparation of pharmaceutical preparations, human urine
and human plasma
To obtain pharmaceutical solutions for quantification,
eight carvedilol tablets containing 12.5 or 25 mg drug
were powdered, mixed and weighted. Required amount
of the resultant material containing 10 mg carvedilol
Figure 2 Schematic diagram of the proposed method.
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tion, the solution was transferred into a 100 ml volu-
metric vessel and diluted with ultra pure water. In order
to set the concentration of carvedilol within the linear
response range, further dilution was performed.
For preparing human plasma samples, different concen-
trations of carvedilol were added to one milliliter of human
plasma. After this step, the real sample was deproteinized
using 5 ml of acetonitrile. After centrifugation (12 min,
4000 r.p.m), 2.0 ml of the upper phase (clear condition)
was diluted with ultra pure water and 10.0 ml of the ob-
tained sample was utilized for quantitation.
In order to prepare human urine samples, ten milliliters
of urine were centrifuged (5 min, 4000 r.p.m). Then,
2.0 ml of the upper clear phase was placed in centrifuge
test tube and different amount of carvedilol was added toFigure 3 Fluorescence spectra of reagent blank and carvedilol. (A) Fluorescen
(B) Fluorescence spectra of carvedilol within linear dynamic range (10, 50, 100
parameters: sample volume 10 ml; IL 60 mg; NaPF6 175 mg; pH 9; temperaturthis and diluted to 10.0 ml. Finally, the defined quantita-
tion procedure was performed.
Results and discussion
In recent work, a simple and benign sample pretreat-
ment method based on the application of ILs was com-
bined with fluorescence spectrometry for enrichment
and determination carvedilol in real samples. Main pa-
rameters affecting the accuracy and precision of the pro-
posed approach were investigated and optimized values
were obtained.
Fluorescence spectra properties and linear dynamic range
Native Fluorescence intensities of molecules with π-
electron and cyclic structure are relatively high. As a
result, measurement of fluorescence intensity provides ace spectrum of reagent blank after applying microextraction procedure.
, 150, 250 μg l−1) after applying microextraction procedure. Applied
e 50°C; λex 285 ± 5 nm; λem 345 ± 5 nm.
Figure 5 Effect of PF6
− Applied parameters: Carvedilol concentration
100 μg l−1; Sample volume 10 ml; IL 60 mg; pH 9; temperature 50°C;
λex 285 ± 5 nm; λem 345 ± 5 nm. Indicated analytical signals are
the average of three independent measurements and error bars
correspond to their standard deviations.
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ing the designed microextraction procedure, fluorescence
spectra of carvedilol (100 μg l−1) was recorded (Figure 3).
In this study, emission peaks were recorded at 345 ± 5 nm
(excitation wave length was fixed at 285 ± 5 nm).
In order to evaluate the spectra properties of reagent
blank, sample pretreatment method was performed
without analyte of interest and the fluorescence spectra
were recorded at 345 ± 5 nm. No main measurable in-
fluence of reagent blank on the quantitative analysis of
carvedilol was observed. As a result, these excitation and
emission wavelengths were selected for further quantita-
tion of carvedilol.
Kind of ionic liquid
Based on the results obtained in our previous studies
[18,19], three factors must be considered, in order to se-
lect a proper IL: (a) the density of IL as the extraction
solvent must be higher than aqueous media, (b) IL must
illustrate a desire hydrophobicity, (c) IL must be liquid
and (d) these ionic material must be inexpensive. ILs
with imidazolium scaffold which contain Cl−, BF4
− and
CF3SO3
− show hydrophilic properties and those contain
PF6
− and (CF3SO2)2 N
− show hydrophobic properties.
According to these factors, [Hmim][PF6] was used as
an optimum microextraction solvent in all tests.
Optimization of diluting solvent
The viscosity of ionic liquids is relatively high; hence their
direct transfer into the micro-cell of spectrofluorimeter
for analyzing carvedilol is difficult. As a result, enriched-
phase was conditioned and diluted. For this goal, some
conditioner solvents such as methanol, ethanol, aceto-
nitrile and acetone were evaluated as the diluting solvent.
The obtained data showed that reproducible and sensitiveFigure 4 Effect of IL as the microextraction phase. Applied parameters:
Carvedilol concentration 100 μg l−1; sample volume 10 ml; NaPF6
175 mg; pH 9; temperature 50°C; λex 285 ± 5 nm; λem 345 ± 5 nm.
Indicated analytical signals are the average of three independent
measurements and error bars correspond to their standard deviations.signals were obtained in using ethanol as a conditioner
agent. Due to the better data stability and ethanol environ-
mental safety (less toxicity), this organic solvent was pre-
ferred and used in all experiments.
Optimization of IL amount
As it was mentioned, in this microextraction procedure,
IL was applied as the microextraction phase. In this kind
of sample pretreatment method, one of the major pa-
rameters affecting the performance is the amount of IL.
This parameter has a significant effect on the reproduci-
bility and sensitivity. In order to optimize the amount of
extraction solvent, this parameter was tested within the
range of 10–100 mg (Figure 4). Stable and sensitive
fluorescence signals were obtained at 60 mg and this
value was used for the rest of the work.Figure 6 Effect of pH. Applied parameters: Carvedilol concentration
100 μg l-1; sample volume 10 ml; IL 60 mg; NaPF6 175 mg; temperature
50°C; λex 285 ± 5 nm; λem 345 ± 5 nm. Indicated analytical signals
are the average of three independent measurements and error
bars correspond to their standard deviations.
Table 1 Analytical characteristics of the presented work
Analytical factor Values
Linear analytical response range (μg l−1) 10-250
Correlation coefficient (R2) 0.9980
LODa (μg l−1) 1.7
RSDb (%) (n = 4) (Ccarvedilol = 100 μg l−1) 3.8
PFc 50
Sample volume (mL) 10
aLimit of detection.
bRelative standard deviation.
cThe ratio of diluted settled phase volume to aqueous volume gives the
preconcentration factor (PF).





RSD (%) Recovery (%)
Urine 50 53.2 6.1 106.4
100 98.3 5.9 98.3
150 146.1 3.8 97.4
Plasma 50 44.6 5.6 89.2
100 107.3 7.1 107.3
150 154.8 4.2 103.2
aAverage of four independent measurements.
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− amount and ionic strength
As it was demonstrated in our previous works [18,19],
dissolving a common ion of IL like PF6
−, significantly re-
duce the solubility of IL. This act improves the extrac-
tion performance of carvedilol and provides better
analytical sensitivity. Effect of this parameter was exam-
ined in the range of 0–250 mg (see Figure 5). A value of
175 mg was selected as an optimum value, in order to
obtain proper signal stability and reproducibility.
One of the most important parameters which affects
on the extraction performance is ionic strength of the
aqueous media. An increase in ionic strength causes a
considerable increase in solubility of IL. As a result, the
volume of the settled phase depends on the salt content
of the sample solution. This phenomenon has a negative
influence on the stability of analytical data. Fortunately,
presence of PF6
− (as a common ion) solves this problem
and fixes the volume of the enrich phase. The effect of
ionic strength was studied within the range of 0–40%
(w/v) using NaNO3 as an electrolyte. In the studied
range, no significant influence on fluorescence signal
























1.7 10-250 This work
aDispersive liquid-liquid microextraction.
bSolid phase extraction-capillary electrophoresis.
cLiquid-liquid extraction.Optimization of pH
In the case of microextraction of molecules like carve-
dilol, which have ionizable property, pH of the aqueous
media reveals a significant role. In order to obtain the
highest extraction efficiency, the uncharged condition of
carvedilol must be prevalent (pKa value of carvedilol is
7.97) [22]. The effect of sample pH on the analytical sen-
sitivity and reproducibility was tested within the range of
2–12 (Figure 6). In the recent experiments, HCl and
NaOH were used for adjusting the pH. Based on the re-
sults obtained in this study, in order to obtain a com-
promise between sensitivity and reproducibility, pH 9
was selected for further experiments.
Influence of temperature
In this microextraction procedure, IL-phase is dispersed
into the aqueous media under increasing the temperature.
The effect of this parameter was evaluated in the range of
25–80°C. Finally, a temperature of 50°C was used as an
optimum value. In order to collect the IL-phase after
extraction, the sample solution must be cooled. For the
recent goal, the aqueous media was placed in ice-water
bath and kept at 0°C for 7 min.
Interference study
For studying the possible interferences coming form
other compounds, which exist in real samples, some ions
and compounds were subjected to the recent combined
methodology. In this investigation, the effect of 100-fold
of K+, Na+, Mg+, F−, Cl−, NO3
−, SO4
2−, glucose, urea,
lactic acid, sucrose, ascorbic acid and fructose as the
interfering or quenching agents on the determination ofTable 4 Analysis of carvedilol tablets by the present work







Error (%)b Error (%)c
12.5 12.3 (±0.5) 12.6 (±0.4) −1.6 −2.9
25 25.5 (±1.0) 25.7 (±1.1) +2.0 −0.7
aValues in parenthesis give the standard deviation based on four determinations.
bError against the tablet value.
cError against the reported method.
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nals over than 4.5% was observed.
Analytical figures of merits
Linear analytical response range was defined by analyzing
standard solutions of carvedilol. The obtained results
revealed that analytical responses are linear from 10 to
250 μg l−1. Other analytical figures of merits obtained by
the ionic liquid phase microextraction-spectrofluorimetry
are shown in Table 1. Limit of detection (LOD) was deter-
mined using a conventional equation, LOD= ksbl/m. This
equation is resulted from the equation showed below:
Sm ¼ Sbl þ ksbl
Sm ¼ mcm þ Sbl
cm ¼ Sm−Sblm ¼
ksbl
m
Sm, Sbl, sbl, K, m and Cm show the minimum distin-
guishable analytical signal, average of blank analytical
signal, blank standard deviation, constant value equal
with 3 (confidence level of 95%), calibration graph slope
and detection limit, respectively. Using this way, a value
of 1.7 μg l−1 carvedilol was achieved. In order to determine
the relative standard deviation (RSD), four 100 μg l−1 of
carvedilol was subjected to the designed methodology and
finally a value of 3.8% was obtained.
Comparison with reported methods
In order to show the analytical advantages of the pro-
posed method for the quantitation of carvedilol, some
details were compared with reported methods in litera-
ture, and these results are shown in Table 2. As it can be
seen, considerable LOD and relatively wide dynamic
range were obtained. In addition, in most of the reported
methods, tedious sample pretreatment procedures, toxic
solvents and expensive analytical instrument have been
used for quantification. In contrast, in the proposed
method, a rapid, benign and simple ionic liquid phase
microextraction was utilized for preconcentration and
extraction of carvedilol. No hazardous material was used
in this sample pre-treatment method. In addition, an
inexpensive and sensitive analytical instrument was ap-
plied for quantitation.
Analysis of carvedilol in real samples
In order to demonstrate the analytical application of the
presented technique, real samples including human
urine and human plasma were spiked with different
amounts of carvedilol and analyzed. Results of this in-
vestigation are shown in Table 3. At it can be seen, the
averages of recoveries are placed in the range of 97.4-
106.2% (urine) and 89.2-107.3% (plasma). It can be con-
cluded that in the case of accuracy and reproducibility,satisfactory results were obtained. In the next step, some
commercial pharmaceutical formulations involving car-
vedilol capsules and tablets were subjected to the
designed method, in order to determine concentration
of carvedilol (Table 4). The results obtained with the
present work were compared with a reported method
[5]. These data reveal the practical analytical application
of the proposed method for analyzing the analyte of
interest in pharmaceutical preparations.
Conclusion
A rapid, benign and simple ionic liquid phase micro-
extraction was utilized for preconcentration and extrac-
tion of carvedilol. The enriched-phase was introduced
to spectrofluorimeter for quantitation of carvedilol. No
toxic and hazardous material was used in this sample
pre-treatment method. In addition, an inexpensive and
sensitive analytical instrument was applied for quantita-
tive measurements. Finally, the combined methodology
was successfully applied for quantitation of carvedilol in
real samples.
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